Pages

Monday, June 22, 2020

Pharma Reviews: COVID India: Cipla to Sell Antiviral Drug Remdesivir as 'Cipremi'

In May, Gilead Sciences signed non-exclusive voluntary licensing agreements with six Indian pharmaceutical companies to boost the supply of ...
Read more: COVID India: Cipla to Sell Antiviral Drug Remdesivir as 'Cipremi'